Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Atypical neuroleptics and new antidepressants in the treatment of neurological disorders
Autore:
Bayas, A; Kornhuber, J; Naumann, M;
Indirizzi:
Univ Wurzburg, Neurol Klin, D-97080 Wurzburg, Germany Univ Wurzburg Wurzburg Germany D-97080 l Klin, D-97080 Wurzburg, Germany Univ Erlangen Nurnberg, Psychiat Klin, D-8520 Erlangen, Germany Univ Erlangen Nurnberg Erlangen Germany D-8520 D-8520 Erlangen, Germany
Titolo Testata:
AKTUELLE NEUROLOGIE
fascicolo: 2, volume: 28, anno: 2001,
pagine: 62 - 73
SICI:
0302-4350(200103)28:2<62:ANANAI>2.0.ZU;2-F
Fonte:
ISI
Lingua:
GER
Soggetto:
SEROTONIN-REUPTAKE INHIBITOR; PARKINSONS-DISEASE PATIENTS; TENSION-TYPE HEADACHE; LEWY BODY DEMENTIA; DIABETIC NEUROPATHY SYMPTOMS; LEVODOPA-INDUCED DYSKINESIAS; DRUG-INDUCED PSYCHOSIS; DOUBLE-BLIND TRIAL; TARDIVE-DYSKINESIA; DOPAMINOMIMETIC PSYCHOSIS;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
140
Recensione:
Indirizzi per estratti:
Indirizzo: Bayas, A Univ Wurzburg, Neurol Klin, Josef Schneider Str 11, D-97080 Wurzburg, Germany Univ Wurzburg Josef Schneider Str 11 Wurzburg Germany D-97080ny
Citazione:
A. Bayas et al., "Atypical neuroleptics and new antidepressants in the treatment of neurological disorders", AKT NEUROL, 28(2), 2001, pp. 62-73

Abstract

Compared to the classical drugs, atypical neuroleptics and new antidepressants are characterised by different mechanisms of action and, in a number of aspects, by a more favourable side effect profile. Though primarily applied in psychiatric disorders these properties prompted their use in neurological diseases, where side effects of classical therapeutics, such as tricyclic antidepressants, are often a major concern. For example, atypical neuroleptics, like clozapine, were successfully applied for the treatment of I-dopa-induced psychosis in Parkinson's disease without deterioration of motorfunctions. New antidepressants, like fluoxetine, have been shown to be effective in emotionalism. This article provides an overview of the use of atypical neuroleptics and new antidepressants (focused on selective serotonin reuptake inhibitors) in the treatment of neurological disorders.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/04/20 alle ore 06:11:02